Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...

Dorian LPG Ltd. (the "Company," "Dorian LPG," "we," "us," and "our"), a leading owner and operator of modern very large gas carriers ("VLGCs"), today reported its financial results for the three ...

Omega Healthcare Investors, Inc. (NYSE: OHI) (the "Company" or "Omega") announced today its results for the quarter and year ended December 31, 2025.

Sell-in / Sell-through: 'Sell-in' refers to product sold to retailers, while 'sell-through' measures actual end-consumer sales at retail.

Please note that during today's call, system sales and operating profit growth will exclude the impact of foreign currency.

Veralto (NYSE: VLTO) (the "Company"), a global leader in essential water and product quality solutions dedicated to Safeguarding the World's Most Vital Resources™, announced results for the fourth ...

By Dawn Chmielewski and Helen Coster LOS ANGELES/NEW YORK, Jan 31 (Reuters) - Three months into her tenure, CBS News ...

Winning championships is the goal, but for the front office, the real scoreboard is the balance sheet. In an era where media ...

Boardroom was in Berlin as Audi unveiled its F1 team and R26 car, charting a path of progress, a new team culture, and ...

National Storage REIT is agreeing to a $4.0 billion AUD privatization transaction with entities (and funds) affiliated with ...

Rare disease clinical trials are smaller and often use surrogate endpoints, reducing costs but posing unique operational ...

SIR Royalty Income Fund (TSX: SRV.UN) (the "Fund") today announced that, as of January 1, 2026, one new restaurant was added to the Royalty Pooled Restaurants (the "Royalty Pool") from which the Fund ...